Bosh sahifa000105 • KRX
add
Yuhan Corp Preference Shares
Yopilish kursi
88 000,00 ₩
Kunlik diapazon
85 400,00 ₩ - 88 300,00 ₩
Yillik diapazon
77 500,00 ₩ - 117 200,00 ₩
Bozor kapitalizatsiyasi
7,61 trln KRW
Oʻrtacha hajm
3,18 ming
Narx/foyda
33,08
Dividend daromadliligi
0,70%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 546,07 mlrd | 10,07% |
Joriy xarajat | 185,79 mlrd | 17,50% |
Sof foyda | 114,43 mlrd | 1 094,12% |
Sof foyda marjasi | 20,96 | 1 003,45% |
Har bir ulushga tushum | 1,53 ming | 1 094,81% |
EBITDA | 44,17 mlrd | 844,26% |
Amaldagi soliq stavkasi | 8,91% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 378,08 mlrd | 14,33% |
Jami aktivlari | 3,22 trln | 9,48% |
Jami passivlari | 858,64 mlrd | 8,50% |
Umumiy kapital | 2,36 trln | — |
Tarqatilgan aksiyalar | 74,76 mln | — |
Narxi/balansdagi bahosi | 2,85 | — |
Aktivlardan daromad | 2,15% | — |
Kapitaldan daromad | 2,57% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 114,43 mlrd | 1 094,12% |
Operatsiyalardan naqd pul | 7,70 mlrd | -85,62% |
Sarmoyadan naqd pul | -11,78 mlrd | 38,27% |
Moliyadan naqd pul | -2,68 mlrd | -107,14% |
Naqd pulning sof oʻzgarishi | -8,29 mlrd | -110,81% |
Boʻsh pul | -68,14 mlrd | -2 056,14% |
Haqida
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
CEO
Tashkil etilgan
1926
Sayt
Xodimlar soni
2 067
